Basic Information
NAUSICALM TABLET 50MG
TABLET
Regulatory Information
SIN15193P
March 20, 2017
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XR06AE03
Company Information
Active Ingredients
Cyclizine hydrochloride
Strength: 50mg
Detailed Information
Contraindications
**Contraindications** Nausicalm should not be given to individuals with known hypersensitivity to cyclizine or in individuals with severe heart failure.
Indication Information
**Indications** Nausicalm is indicated for the prevention and treatment of nausea and vomiting associated with motion sickness and radiotherapy.